To include your compound in the COVID-19 Resource Center, submit it here.

Tracking TrkB agonists

TrkB agonists aren't what they seem

It turns out that neurotrophic TrkB agonists used in many publications aren't TrkB agonists after all, according to a recent Science Signaling paper from Columbia University and the Broad Institute of MIT and Harvard. The publication reinforces concerns raised in a 2014 paper from the CHDI Foundation Inc. and is an illustration of why high-profile journals and funding agencies should support "negative" data studies at a time when translational research is grappling

Read the full 721 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury


Article Purchase

This article may not be distributed to non-subscribers